158 related articles for article (PubMed ID: 34813872)
1. Defining the decision problem: a scoping review of economic evaluations for Clostridioides difficile interventions.
Richardson M; Erman A; Daneman N; Miller FA; Sander B
J Hosp Infect; 2022 Mar; 121():22-31. PubMed ID: 34813872
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial stewardship and infection prevention interventions targeting healthcare-associated
Okeah BO; Morrison V; Huws JC
BMJ Open; 2021 Aug; 11(8):e051983. PubMed ID: 34348956
[TBL] [Abstract][Full Text] [Related]
3. Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent
Scott RD; Slayton RB; Lessa FC; Baggs J; Culler SD; McDonald LC; Jernigan JA
Antimicrob Resist Infect Control; 2019; 8():17. PubMed ID: 30680153
[TBL] [Abstract][Full Text] [Related]
4. Use of diagnostic and antimicrobial stewardship practices to improve
Sullivan KV; Gallagher JC; Leekha S; Morgan DJ; Morita K; Rock C; Claeys KC
Infect Control Hosp Epidemiol; 2022 Jul; 43(7):930-934. PubMed ID: 34376271
[TBL] [Abstract][Full Text] [Related]
5. Application of consolidated framework for implementation research to improve Clostridioides difficile infection management in district hospitals.
Legenza L; Coetzee R; Rose WE; Esack T; Crombie K; Mina M; Safdar N; Barnett SG
Res Social Adm Pharm; 2022 Dec; 18(12):4100-4111. PubMed ID: 35981939
[TBL] [Abstract][Full Text] [Related]
6. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
Savage TJ; Sandora TJ
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402
[TBL] [Abstract][Full Text] [Related]
7. A review of epidemiological models of Clostridioides difficile transmission and control (2009-2021).
Lanzas C; Jara M; Tucker R; Curtis S;
Anaerobe; 2022 Apr; 74():102541. PubMed ID: 35217149
[TBL] [Abstract][Full Text] [Related]
8. Strategies to prevent adverse outcomes following
Rauseo AM; Olsen MA; Reske KA; Dubberke ER
Expert Rev Anti Infect Ther; 2020 Mar; 18(3):203-217. PubMed ID: 31976779
[No Abstract] [Full Text] [Related]
9. Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection.
Barker AK; Scaria E; Safdar N; Alagoz O
JAMA Netw Open; 2020 Aug; 3(8):e2012522. PubMed ID: 32789514
[TBL] [Abstract][Full Text] [Related]
10. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
Hawes AM; Desai A; Patel PK
Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
[TBL] [Abstract][Full Text] [Related]
11. Chasing the rate: An interrupted time series analysis of interventions targeting reported hospital onset
Doll ME; Zhao J; Kang L; Rittmann B; Alvarez M; Fleming M; Cooper K; Stevens MP; Bearman G
Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1142-1147. PubMed ID: 32493530
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic Stewardship and Inpatient Clostridioides difficile Testing in Solid Organ Transplant Recipients: The Need for Multilevel Checks and Balances.
Kueht M; Kharsa A; Mujtaba M; Kulkarni R; Britt R; Lea AS; Hafiz G; Fair J; Reynoso D
Transplant Proc; 2022 Apr; 54(3):605-609. PubMed ID: 35249732
[TBL] [Abstract][Full Text] [Related]
13. How to: prophylactic interventions for prevention of Clostridioides difficile infection.
Reigadas E; van Prehn J; Falcone M; Fitzpatrick F; Vehreschild MJGT; Kuijper EJ; Bouza E;
Clin Microbiol Infect; 2021 Dec; 27(12):1777-1783. PubMed ID: 34245901
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Clostridioides difficile Diagnostic Stewardship Interventions on the Diagnosis of Hospital-Onset Clostridioides difficile Infections.
Kang M; Abeles SR; El-Kareh R; Taplitz RA; Nyheim E; Reed SL; Jenkins IH; Seymann GB; Myers FE; Torriani FJ;
Jt Comm J Qual Patient Saf; 2020 Aug; 46(8):457-463. PubMed ID: 32576438
[TBL] [Abstract][Full Text] [Related]
15. Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study.
Stephenson B; Lanzas C; Lenhart S; Ponce E; Bintz J; Dubberke ER; Day J
BMC Infect Dis; 2020 Oct; 20(1):799. PubMed ID: 33115427
[TBL] [Abstract][Full Text] [Related]
16. Decreasing ICU-associated
Safdar N; Parmasad V; Brown R; Carayon P; Lepak A; O'Horo JC; Schulz L
BMJ Open; 2021 Jun; 11(6):e046480. PubMed ID: 34187821
[TBL] [Abstract][Full Text] [Related]
17. Cutting edges in Clostridioides difficile infections.
Durovic A; Tschudin-Sutter S
Swiss Med Wkly; 2021 Sep; 151():w30033. PubMed ID: 34652093
[TBL] [Abstract][Full Text] [Related]
18. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
[TBL] [Abstract][Full Text] [Related]
19. Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence.
McFarland LV; Johnson SB; Evans CT
Am J Infect Control; 2021 Mar; 49(3):375-384. PubMed ID: 32791261
[TBL] [Abstract][Full Text] [Related]
20. Prevention of Clostridioides difficile in hospitals: A position paper of the International Society for Infectious Diseases.
Doll M; Marra AR; Apisarnthanarak A; Al-Maani AS; Abbas S; Rosenthal VD
Int J Infect Dis; 2021 Jan; 102():188-195. PubMed ID: 33122100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
